Prognostic immune markers in esophageal cancer patients managed with trimodal therapy.
Farrugia MK, Repasky EA, Chen M, Attwood K, Catalfamo K, Rosenheck H, Yao S, Mattson DM, Mukherjee S, Kukar M, Witkiewicz AK, Singh AK.
Farrugia MK, et al. Among authors: mukherjee s.
Cancer Immunol Immunother. 2025 Jan 3;74(2):57. doi: 10.1007/s00262-024-03891-3.
Cancer Immunol Immunother. 2025.
PMID: 39751903
Free PMC article.